Bone Biologics Inc. announced today that it has received a US Patent Office Notice of Allowance of patent claims which protect a method of production for the UCB-1 (NELL-1) recombinant protein that Bone Biologics uses in the bone repair/regeneration technology in its lead product.
The details can be read here.
No comments:
Post a Comment